The role of motivation and cognition in psychopathology and treatment; clinical psychophysiology; ADHD; smoking
230 Park Hall
Buffalo NY, 14260-4110
Phone: (716) 645-0192
EVarQuit. This ongoing NCI-funded randomized controlled trial not only extends our evaluation of an extinction-learning approach to improve treatment outcome but also provides tests of candidate treatment mechanisms. To accomplish the latter, all 320 participants complete two lab sessions evaluating changes in cigarette and food reinforcement and craving, 9 weeks of ecological momentary assessment (EMA), and provide repeated samples to assess the time course of medication (varenicline) levels and its role in treatment response. Collaborators include Drs Martin Mahoney, Stephen Tiffany, Craig Colder, Rachel Tyndale, Jennifer Wray, and Julie Gass. Find out more at quitforgoodwny.com. A CTSA-funded supplement to this trial is evaluating two promising reinforcement approaches for maintaining EMA adherence in the trial.
Additional active research includes multiple student-led projects, including:
The lab also has recent/ongoing/proposed studies related to the following: